Marcel Rozencweig

5.1k citations
151 papers · 4.0k · 1 hit paper · h-index 30

Impact in

  • Oncology top 1%
    • Cancer Treatment and Pharmacology
    • Metal complexes synthesis and properties
    • Lung Cancer Research Studies
    • Chemotherapy-induced organ toxicity mitigation

Papers in

    • Cancer Treatment and Pharmacology 47
    • Metal complexes synthesis and properties 13
    • Cancer therapeutics and mechanisms 23

Marcel Rozencweig

147 papers receiving 3.7k citations

Marcel Rozencweig's Hit Papers

Cis-diamminedichloroplatinum (II) 1977 · 373 citations
3730+16+32Years since publication100200300

Peers

Marcel Rozencweig
Comparison fields: 5 of 143
  • Oncology 1.7k
  • Pathology and Forensic Medicine 561
  • Cardiology and Cardiovascular Medicine 569
  • Otorhinolaryngology 108
  • Hematology 279
Replace Irwin H. Krakoff with:
Irwin H. Krakoff United States
Sewa S. Legha United States
Kenneth R. Hande United States
Scott Wadler United States
Jeffrey A. Gottlieb United States
J.T. Thigpen United States
R. Bugat France
Philip S. Schein United States
S.B. Kaye United Kingdom
W.W. ten Bokkel Huinink Netherlands
Marcel Rozencweig relative to Irwin H. Krakoff United States Irwin H. Krakoff's profile →
Citations per field
00.5×2.6×
Irwin H. Krakoff · 1×
Citations per year

Countries citing papers authored by Marcel Rozencweig

Since Specialization
Citations

This map shows the geographic impact of Marcel Rozencweig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcel Rozencweig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcel Rozencweig more than expected).

Fields of papers citing papers by Marcel Rozencweig

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marcel Rozencweig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcel Rozencweig. The network helps show where Marcel Rozencweig may publish in the future.

Co-authors

The 25 scholars most cited alongside Marcel Rozencweig, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Marcel Rozencweig Line = papers co-authored together Marcel Rozencweig links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 151 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Cis-diamminedichloroplatinum (II)
Hit paper breakdown →
1977373
2 1977319
3
Toxic effects of cis-dichlorodiammineplatinum(II) in man.
1980285
4 2009266
5 1985162
6
The cardiotoxicity of anticancer agents.
1982161
7 2015155
8 1981129
9 1977106
10 198891
11 201476
12
Overview of Taxol safety.
199363
13 198355
14
Lung cancer : progress in therapeutic research
197954
15 199048
16
Clinical predictivity of transplantable tumor systems in the selection of new drugs for solid tumors: rationale for a three-stage strategy.
198348
17 198448
18
Animal toxicology for early clinical trials with anticancer agents.
198147
19 198946
20 198546

About Marcel Rozencweig

Marcel Rozencweig is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Cancer Research, having authored 151 papers that have together received 4.0k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (47 papers), Cancer therapeutics and mechanisms (23 papers), Chemotherapy-induced organ toxicity mitigation (15 papers), Chemotherapy-induced cardiotoxicity and mitigation (14 papers), Lung Cancer Treatments and Mutations (14 papers), Metal complexes synthesis and properties (13 papers), Chronic Lymphocytic Leukemia Research (9 papers) and HIV/AIDS drug development and treatment (6 papers). The work is most often cited by research in Oncology (1.7k citations), Pathology and Forensic Medicine (561 citations), Cardiology and Cardiovascular Medicine (569 citations), Otorhinolaryngology (108 citations) and Hematology (279 citations). Marcel Rozencweig has collaborated with scholars based in Belgium, United States and Switzerland. Frequent co-authors include Franco M. Muggia, Daniel D. Von Hoff, Renzo Canetta, Von Hoff, Milan Slavik, Maurice J. Staquet, Stephen K. Carter, Maxwell W. Layard, Martine Piccart and Laurie Smaldone. Their work appears in journals such as Cancer Chemotherapy and Pharmacology, Journal of Clinical Oncology, Investigational New Drugs, Cancer and Cancer Treatment Reviews.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact